CAMP4 THERAPEUTICS CORPORATION (CAMP) Live Share Price, Invest From India

CAMP4 THERAPEUTICS CORPORATION Stock Performance

as on April 25, 2026 at 6:59 am IST

Day's Low
Day's High
$4.11
Day's Price Range
$4.53
$4.50
8.67%
Downside
0.67%
Upside
52 Week's Low
52 Week's High
$1.31
52-Week Price Range
$7.75
$4.50
71.00%
Downside
72.22%
Upside

CAMP4 THERAPEUTICS CORPORATION share price movements today

Previous Close: $4.44
Open: $4.42
Volume: 166.8K
Day's Low - High: $4.11 - $4.53
52 Week Low - High: $1.31 - $7.75

CAMP4 THERAPEUTICS CORPORATION Historical Returns

1 Month Return: -6.53 %
3 Month Return: + 10.72 %
1 Year Return: + 116.59 %
3 Year Return: -91.53 %
5 Year Return: -98.57 %

CAMP4 THERAPEUTICS CORPORATION Stock Fundamentals & Key Indicators

Check CAMP4 THERAPEUTICS CORPORATION market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$230.6M

EPS (TTM)

-0.7667

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-50.4M

Revenue (TTM)

3.5M

Profit Margin

0.00%

Return On Equity TTM

-145.07%

CAMP4 THERAPEUTICS CORPORATION vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CAMP4 THERAPEUTICS CORPORATION with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
CAMP4 THERAPEUTICS CORPORATION	SELL	$230.6M	-98.57%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.8B	123.48%	131.7	8.45%
Vertex Pharmaceuticals Inc	BUY	$109.4B	97.47%	28.09	32.94%
BeiGene, Ltd.	NA	$33.4B	NA	121.78	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.5B	53.81%	18.11	31.41%

Stock Returns calculator for CAMP4 THERAPEUTICS CORPORATION Stock including INR - Dollar returns

The CAMP4 THERAPEUTICS CORPORATION stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

CAMP4 THERAPEUTICS CORPORATION investment value today

Current value as on today

₹2,42,226

Returns

₹1,42,226

(+142.23%)

Returns from CAMP4 THERAPEUTICS CORPORATION Stock

₹1,19,512 (+119.51%)

Dollar Impact

₹22,713 (+22.71%)

Analyst Recommendation on CAMP4 THERAPEUTICS CORPORATION Stock

Based on 9 analysts

SELL

11.11%

Buy

44.44%

Hold

44.44%

Sell

Based on 9 analysts, 44.44% of analysts recommend a 'SELL' rating for CAMP4 THERAPEUTICS CORPORATION. Average target price of $8.2

CAMP4 THERAPEUTICS CORPORATION Share Price Target

Get share price movements and forecasts by analysts on CAMP4 THERAPEUTICS CORPORATION.

What analysts predicted

45.12%UPSIDE

Target Price

$8.2

Current Price

$4.5

Analyzed by

9 Analysts

Target

$8.20

CAMP4 THERAPEUTICS CORPORATION target price $8.2, a slight upside of 45.12% compared to current price of $4.5. According to 9 analysts rating.

CAMP4 THERAPEUTICS CORPORATION Quarterly Profit & Loss

All numbers in Millions USD

	Nov 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	53	53	-	-	-	0	0	1	0	0
Gross Profit	-	17	-	-	-	0	0	1	0	0
Operating Income	-	-13	-12	-12	-13	-14	-13	-13	-13	-12
EBITDA	-	-13	-12	-12	-13	-13	-12	-12	-14	-12
Interest Expense	-	1	-	-	-	-	-	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-	-12	-12	-12	-13	-13	-12	-12	-15	-40
Income Tax Expense	-	0	-	-	-	0	-	-	-	-
Net Income	-85	-12	-12	-12	-13	-13	-12	-12	-15	-40
Net Profit Margin	-158.52%	-24.22%	0.00%	0.00%	0.00%	-2036.66%	-1449.07%	-840.81%	-1899.25%	-11575.86%

CAMP4 THERAPEUTICS CORPORATION Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Feb 2021	Dec 2021	Feb 2022	Dec 2022	Feb 2023	Dec 2023	Feb 2024	Dec 2024	Dec 2025
Total Revenue	308	308	295	295	294	294	0	186	0	3
Gross Profit	122	-	121	-	109	-	0	-	0	1
Operating Income	-3	-	-15	-	-45	-	-51	-	-53	-52
EBITDA	18	-	7	-	-44	-	-50	-	-51	-50
Interest Expense	15	-	15	-	6	-	4	-	-	-
Depreciation	-	-	-	-	0	-	1	-	1	1
Income Before Tax	-20	-	-30	-	-44	-	-49	-	-51	-80
Income Tax Expense	0	-	1	-	1	-	0	-	-	-
Net Income	-21	-21	-31	-31	-44	-32	-49	-93	-51	-80
Net Profit Margin	-6.86%	-6.86%	-10.53%	-10.53%	-14.98%	-11.02%	-14083.14%	-50.08%	-7943.40%	-2298.54%

CAMP4 THERAPEUTICS CORPORATION Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-12	-12	-12	-13	-13	-12	-12	-15	-40
Operating Cash Flow	-11	-11	-13	-9	-11	-14	-10	-11	6
Investing Cash Flow	0	0	0	0	0	0	0	0	-
Financing Cash Flow	0	0	0	0	73	0	0	47	28
Change in Cash	-12	-11	-14	-10	61	-14	-10	36	34

CAMP4 THERAPEUTICS CORPORATION Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	16	18	-79	-56	-27	-44	-49	-51	-80
Operating Cash Flow	66	47	11	28	-4	-38	-44	-45	-29
Investing Cash Flow	-26	-21	-65	-13	-7	-4	0	0	0
Financing Cash Flow	-2	98	-94	-27	-2	100	0	71	75
Change in Cash	38	123	-149	-12	-15	83	-44	25	46

Global Institutional Holdings in CAMP4 THERAPEUTICS CORPORATION

Funds	Holdings
West Paces Advisors Inc	0.01%
Your Advocates Ltd., LLP	0%
Paradigm Capital Management, Inc.	0%
Bridgeway Capital Management, LLC	0%
GSA Capital Partners LLP	0%

See all

Insights on CAMP4 THERAPEUTICS CORPORATION

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CAMP has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Camp4 Therapeutics Corp. has experienced a drawdown of -91.5%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 86.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 1.49M → 348.0K (in $), with an average decrease of 51.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 3 years, CAMP stock has moved down by -91.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -12.43M → -40.28M (in $), with an average decrease of 62.7% per quarter

About CAMP4 THERAPEUTICS CORPORATION

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Organisation	CAMP4 THERAPEUTICS CORPORATION
Headquarters	One Kendall Square, Cambridge, MA, United States, 02139
Industry	Biotechnology
CEO	Mr. Joshua Mandel-Brehm
E-voting on shares	Click here to vote

Key Management of CAMP4 THERAPEUTICS CORPORATION

Name	Title
Mr. Caleb Moore	Chief Business Operations Officer
Ms. Michelle Gates	Senior VP & Chief People Officer
Ms. Alla Sigova Ph.D.	Senior Vice President of Platform
Dr. Satya Kuchimanchi Ph.D.	Senior Vice President of Technical Operations
Mr. Joshua Mandel-Brehm	CEO, President & Director
Dr. Richard A. Young Ph.D.	Founder & Independent Director
Dr. Yuri Maricich M.B.A., M.D.	Chief Medical Officer
Dr. Leonard I. Zon M.D.	Founder & Chairman of Scientific Advisory Board

FAQs

What is CAMP4 THERAPEUTICS CORPORATION share price today?

CAMP4 THERAPEUTICS CORPORATION share price today is $4.5 as on April 25, 2026 at 1:29 am IST at the close of the market. CAMP4 THERAPEUTICS CORPORATION share today touched a day high of $4.53 and a low of $4.11.

What is the 52 week high and 52 week low for CAMP4 THERAPEUTICS CORPORATION share?

CAMP4 THERAPEUTICS CORPORATION share touched a 52 week high of $7.75 on March 9, 2026 and a 52 week low of $1.31 on June 20, 2025. CAMP4 THERAPEUTICS CORPORATION stock price today i.e. April 25, 2026 at 1:29 am IST is closed at $4.5,which is 41.94% down from its 52 week high and 244.83% up from its 52 week low.

What is CAMP4 THERAPEUTICS CORPORATION's market capitalisation today?

CAMP4 THERAPEUTICS CORPORATION market capitalisation is $0.00T as on April 25, 2026 at 1:29 am IST.

How to invest in CAMP4 THERAPEUTICS CORPORATION Stock (CAMP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for CAMP4 THERAPEUTICS CORPORATION on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CAMP4 THERAPEUTICS CORPORATION Shares that will get you 0.3333 shares as per CAMP4 THERAPEUTICS CORPORATION share price of $4.5 per share as on April 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy CAMP4 THERAPEUTICS CORPORATION Stock (CAMP) from India?

Indian investors can start investing in CAMP4 THERAPEUTICS CORPORATION (CAMP) shares with as little as ₹94.22 or $1 (as of April 26, 2026 at 4:54 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.20 in CAMP4 THERAPEUTICS CORPORATION stock (as per the Rupee-Dollar exchange rate as on April 26, 2026 at 4:54 am IST). Based on CAMP4 THERAPEUTICS CORPORATION share’s latest price of $4.5 as on April 25, 2026 at 1:29 am IST, you will get 2.2222 shares of CAMP4 THERAPEUTICS CORPORATION. Learn more about fractional shares .

What are the returns that CAMP4 THERAPEUTICS CORPORATION has given to Indian investors in the last 5 years?

CAMP4 THERAPEUTICS CORPORATION stock has given -98.57% share price returns and 25.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?